Polypeptide—human SR splicing factor 52 and a...

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Rodent cell – per se

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S365000, C435S320100, C435S252330, C536S023500

Reexamination Certificate

active

06908765

ABSTRACT:
The present invention discloses a novel polypeptide-human SR splicing factor 52 and polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technology. The present invention also discloses methods of using the polypeptide in treatment of various disease, such as malignant tumor, blood disease, HIV infection, immunological disease and various inflammation. The present invention also discloses an antagonist againts the polypeptide and the therapeutic use of the same. The present invention also discloses the use of such polynucleotide encoding Human SR splicing factor 52.

REFERENCES:
patent: 97/28186 (1997-08-01), None
Verma et al., Nature, vol. 389, Sep. 18, 1997, pp. 239-242.
Anderson, Nature, vol. 392 suppl., Apr. 30, 1998, pp. 25-30.
Juengst, BMJ, vol. 326, Jun. 28, 2003, pp. 1410-1411.
International Search Report for PCT/CN00/00461.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polypeptide—human SR splicing factor 52 and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide—human SR splicing factor 52 and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide—human SR splicing factor 52 and a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3522526

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.